focus -WSS

focus

author：Wikipedia 2025-09-30 18:43:01 - browse：84

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

knowledge

focus

WSS

What is microchimerism and how does it affect maternal health?

Humans aren't the only ones with an imagination. Rats have it too

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Four alarming medical procedures we’re glad history forgot

How to convince healthy people to buy insurance

Medicare proceeds with plan to claw back hospital funds

hotspot

focus

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Bird flu in dairy cattle: New measures to control spread to humans

Malaria cases in Florida and Texas: Here’s what you need to know

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

23andMe had bad news about my health. I wish a person had delivered it

Medicare proceeds with plan to claw back hospital funds

State Dept. review finds Biden bears some blame for Afghanistan failures

Pancreatic cancer is often deadly, but new discoveries are raising hope

Continuity nursing helped my family in our darkest PICU moments

DeepMind touts AlphaFold's new skills as protein folding AI models face off

explore

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Harvard scientists, with Google, unveil the most detailed brain map ever

Bill would allow buprenorphine prescription for addiction via telehealth

Bill would allow buprenorphine prescription for addiction via telehealth

Pancreatic cancer is often deadly, but new discoveries are raising hope

knowledge

entertainment

focus

explore